The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 15, 2019

Filed:

Sep. 25, 2017
Applicant:

Hanmi Pharm. Co., Ltd., Hwaseong-si, Gyeonggi-do, KR;

Inventors:

Hyun Uk Kim, Busan, KR;

Hyung Kyu Lim, Hwaseong-si, KR;

Sung Hee Hong, Suwon-si, KR;

Dae Jin Kim, Hwaseong-si, KR;

Sung Min Bae, Seongnam-si, KR;

Se Chang Kwon, Seoul, KR;

Assignee:

HANMI PHARM. CO., LTD., Hwaseong-si, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 38/26 (2006.01); C07K 16/00 (2006.01); C12P 21/08 (2006.01); A61K 47/68 (2017.01); C07K 16/42 (2006.01); C07K 16/28 (2006.01); C07K 16/06 (2006.01); A61K 9/08 (2006.01); C07K 14/575 (2006.01); C07K 14/605 (2006.01); A61K 47/26 (2006.01); A61K 39/395 (2006.01); C07K 19/00 (2006.01); G01N 33/50 (2006.01);
U.S. Cl.
CPC ...
A61K 47/68 (2017.08); A61K 9/08 (2013.01); A61K 39/39591 (2013.01); A61K 47/26 (2013.01); A61K 47/6811 (2017.08); C07K 14/57563 (2013.01); C07K 14/605 (2013.01); C07K 16/065 (2013.01); C07K 16/28 (2013.01); C07K 16/4283 (2013.01); C07K 19/00 (2013.01); C07K 2317/50 (2013.01); C07K 2319/30 (2013.01); G01N 33/5047 (2013.01);
Abstract

Provided are a liquid formulation of long-acting insulinotropic peptide conjugate, containing a pharmaceutically effective amount of long-acting insulinotropic peptide conjugate consisting of a physiologically active peptide, insulinotropic peptide, and an immunoglobulin Fc region; and an albumin-free stabilizer, wherein the stabilizer comprises a buffer, a sugar alcohol, and a non-ionic surfactant, and a method for preparing the formulation. For the purpose of preventing microbial contamination, a preservative may be added. The liquid formulation of the present invention is free of human serum albumin and other potentially hazardous factors to body, having no risk of viral contamination, and thus can provide excellent storage stability for insulinotropic peptide conjugates at high concentration.


Find Patent Forward Citations

Loading…